Guest
The scientific community is continuously exploring the potential therapeutic effects of Mesenchymal Stromal Cells (MSCs) in the treatment of COVID-19. Studies suggest that the MSCs' secretome, which includes cytokines and extracellular vesicles, possesses immunomodulatory and anti-inflammatory properties, which can be used as an effective treatment for several diseases, including traditional Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 infection. The COVID-19 pandemic ravages healthcare systems globally, giving impetus for research institutes around the world to explore clinical solutions to aid recovery and reduce the mortality rate of infected individuals. With this being said, the scientific community has been continuously exploring the potential therapeutic effects of Mesenchymal Stromal Cells (MSCs) in the treatment of COVID-19. Studies are suggesting that MSCs' secretome, which includes cytokines and extracellular vesicles, possesses immunomodulatory and ant
